Document Detail


The effect of dexamethasone on growth, mineral balance and bone mineralisation in preterm infants with chronic lung disease.
MedLine Citation:
PMID:  10834526     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSION: The start of steroids is associated with a rapid and significant fall in growth velocity, calcium absorption and calcium and phosphate retention in infants with chronic lung disease with recovery occurring after completion of steroid treatment.
Authors:
A Shrivastava; A Lyon; N McIntosh
Related Documents :
20967846 - Methacholine-induced lung function changes measured with infant body plethysmography.
12232446 - Comparison of subjective and objective measures in recurrently wheezy infants.
10325806 - Raised concentrations of aldehyde lipid peroxidation products in premature infants with...
1628676 - Longitudinal assessment of infant lung function following pregnancies complicated by pr...
17413056 - The effect of the 1995 heat wave in chicago on all-cause and cause-specific mortality.
9605306 - C-reactive protein levels in the extremely premature infant: case studies and literatur...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of pediatrics     Volume:  159     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  2000 May 
Date Detail:
Created Date:  2000-09-14     Completed Date:  2000-09-14     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  380-4     Citation Subset:  IM    
Affiliation:
Department of Paediatrics, Southend General Hospital, Essex, United Kingdom. anupam@shrivastava.freeserve.co.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Density / drug effects*
Calcium / metabolism*
Chronic Disease
Dexamethasone / adverse effects*,  therapeutic use
Female
Glucocorticoids / adverse effects*,  therapeutic use
Growth / drug effects*
Humans
Infant, Newborn
Infant, Premature, Diseases / drug therapy*
Infant, Very Low Birth Weight*
Longitudinal Studies
Lung Diseases / drug therapy*
Male
Phosphates / metabolism*
Prospective Studies
Weight Gain
Chemical
Reg. No./Substance:
0/Glucocorticoids; 0/Phosphates; 50-02-2/Dexamethasone; 7440-70-2/Calcium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Severe hypercalcaemia and respiratory insufficiency associated with infantile hypophosphatasia cause...
Next Document:  Prostate-specific antigen as a marker of prostate disease.